Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryoport (CYRX) Notes Payables (2016 - 2025)

Cryoport (CYRX) has disclosed Notes Payables for 10 consecutive years, with $163000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Notes Payables rose 13.99% to $163000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $163000.0, a 13.99% increase, with the full-year FY2025 number at $163000.0, up 13.99% from a year prior.
  • Notes Payables was $163000.0 for Q4 2025 at Cryoport, up from $149000.0 in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $1.1 million in Q4 2021 to a low of $60000.0 in Q4 2022.
  • A 5-year average of $314571.4 and a median of $146000.0 in 2023 define the central range for Notes Payables.
  • Peak YoY movement for Notes Payables: plummeted 94.48% in 2022, then surged 148.33% in 2023.
  • Cryoport's Notes Payables stood at $1.1 million in 2021, then tumbled by 94.48% to $60000.0 in 2022, then soared by 148.33% to $149000.0 in 2023, then decreased by 4.03% to $143000.0 in 2024, then increased by 13.99% to $163000.0 in 2025.
  • Per Business Quant, the three most recent readings for CYRX's Notes Payables are $163000.0 (Q4 2025), $149000.0 (Q1 2025), and $143000.0 (Q4 2024).